PCYC

Pharmacyclics, Inc. News Headlines

$168.75
*  
1.28
0.76%
Get PCYC Alerts
*Delayed - data as of Jan. 30, 2015  -  Find a broker to begin trading PCYC now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Pharmacyclics Inc. (PCYC) Is Surging On Forecast
1/13/2015 9:35:00 AM - RTT News


Pharmacyclics Reports Preliminary Results and 2015 Outlook - Analyst Blog
1/13/2015 7:10:00 AM - Investopedia


3 Cheap Dividend Stocks You Can Buy Right Now
1/9/2015 3:00:02 PM - Motley Fool


Pharmacyclics Reports Encouraging Data on Cancer Drug - Analyst Blog
1/6/2015 5:45:00 PM - Zacks.com


Pharmacyclics Reports Encouraging Data on Cancer Drug - Analyst Blog
1/6/2015 5:45:00 AM - Investopedia


Individual Investor Portfolio: Solid Results, But Energy Sell-Off And Biotechnology Add Volatility
1/2/2015 10:45:00 AM - Seeking Alpha


Bull of the Day: Incyte (INCY) - Bull of the Day
1/2/2015 1:00:00 AM - Zacks.com


Bull of the Day: Incyte (INCY) - Bull of the Day
1/1/2015 1:00:00 PM - Investopedia


Idera Gets Orphan Drug Status for its Oncology Candidate - Analyst Blog
12/31/2014 4:15:00 PM - Zacks.com


Stocks Holding On To Modest Gains In Mid-Day Trading - U.S. Commentary
12/31/2014 11:57:00 AM - RTT News


Idera Gets Orphan Drug Status for its Oncology Candidate - Analyst Blog
12/31/2014 4:15:00 AM - Investopedia


DoctoRx Positions For 2015: I Have Cut Back On My Exposure To All Biotech Substantially
12/30/2014 7:05:00 AM - Seeking Alpha


Pharmacyclics Reveals FDA Action Date for Imbruvica sNDA - Analyst Blog
12/23/2014 6:05:00 PM - Zacks.com


Tuesday's ETF Movers: GDXJ, BBH
12/23/2014 1:57:14 PM - BNK Invest


Pharmacyclics Reveals FDA Action Date for Imbruvica sNDA - Analyst Blog
12/23/2014 6:05:00 AM - Investopedia


Can You Guess the Best-Performing Biotech IPO of 2014? (Hint: Shares Rallied 217%)
12/22/2014 7:04:02 AM - Motley Fool


These Biotech Stocks Are Growing Even Faster Than Gilead Sciences
12/21/2014 8:31:02 AM - Motley Fool


Bull of the Day: Seattle Genetics (SGEN) - Bull of the Day
12/18/2014 1:00:00 PM - Investopedia


3 Reasons Johnson & Johnson Could Soar in 2015
12/10/2014 8:03:02 AM - Motley Fool


New Use For AMGN's Old Drug, BLUE In The Pink, Cellceutix Gets A Boost
12/9/2014 12:49:00 AM - RTT News


Pharmacyclics (PCYC) Launches U.S.-Based CLL Registry - Analyst Blog
12/8/2014 6:50:00 PM - Zacks.com


Can Pharmacyclics (PCYC) Run Higher on Strong Earnings Estimate Revisions? - Tale of the Tape
12/3/2014 8:41:00 AM - Zacks.com


Pharmacyclics, J&J Seek Imbruvica Label Expansion in EU - Analyst Blog
12/2/2014 6:05:00 PM - Zacks.com


Up 31% in 2014, is Pharmacyclics Stock Still a Buy?
12/1/2014 9:15:02 AM - Motley Fool


Pharmacyclics Says EMA Accepts Type II Variation Application For IMBRUVICA
12/1/2014 3:37:00 AM - RTT News